New York, NY, United States of America

Iveric Bio, Inc.

USPTO Granted Patents = 6


Trademarks = 2

Forward Citations = 8

Loading Chart...
Loading Chart...

14 inventors (with patents filed for the assignee):

goldMedal Samir Patel (3 out of 3 patents)

silverMedal Richard Everett (3 out of 3 patents)

bronzeMedal Douglas Brooks (3 out of 6 patents)

4.  Shane Xinxin Tian (3 out of 3 patents)

5.  Dilara McCauley (1 out of 44 patents)

6.  Claude Benedict (1 out of 12 patents)

7.  David Epstein (1 out of 15 patents)

8.  Charles Wilson (1 out of 16 patents)

9.  James Rottman (1 out of 12 patents)

10.  Kourous Rezaei (1 out of 1 patent)

11.  Markus Kurz (1 out of 1 patent)

12.  Jeffrey Kurz (1 out of 1 patent)

13.  Thomas Greene McCauley (1 out of 14 patents)

14.  Hemant Khanna (1 out of 6 patents)

15.  Dilara Grate (5 patents)


6 patents:

Company Overview
Iveric Bio is a biotechnology company focused on the discovery and development of novel treatments for age-related retinal diseases. Their innovative therapies aim to preserve and restore vision in patients with degenerative eye conditions. With a strong emphasis on research and development, Iveric Bio is dedicated to advancing the field of ophthalmology and improving the lives of those affected by vision loss.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

6 Patents

#1,028 in New York, NY

#2,697 in New York

#45,007 in US

New York, NY (US)
New York, NY, United States of America
Forward Citations = 8

14 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Iveric Bio, Inc.. Retrieved from https://idiyas.com/company/iveric-bio

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…